AU1564897A - Antisense inhibition of human adhesion molecules - Google Patents

Antisense inhibition of human adhesion molecules

Info

Publication number
AU1564897A
AU1564897A AU15648/97A AU1564897A AU1564897A AU 1564897 A AU1564897 A AU 1564897A AU 15648/97 A AU15648/97 A AU 15648/97A AU 1564897 A AU1564897 A AU 1564897A AU 1564897 A AU1564897 A AU 1564897A
Authority
AU
Australia
Prior art keywords
adhesion molecules
antisense inhibition
human adhesion
human
antisense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15648/97A
Inventor
Matthews O. Bradley
Glenn D Hoke
Che-Hung Lee
Taffy J Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1564897A publication Critical patent/AU1564897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
AU15648/97A 1996-12-02 1996-12-02 Antisense inhibition of human adhesion molecules Abandoned AU1564897A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/019194 WO1998024797A1 (en) 1996-12-02 1996-12-02 Antisense inhibition of human adhesion molecules

Publications (1)

Publication Number Publication Date
AU1564897A true AU1564897A (en) 1998-06-29

Family

ID=22256225

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15648/97A Abandoned AU1564897A (en) 1996-12-02 1996-12-02 Antisense inhibition of human adhesion molecules

Country Status (5)

Country Link
EP (1) EP0950060A4 (en)
JP (1) JP2001505432A (en)
AU (1) AU1564897A (en)
CA (1) CA2273203A1 (en)
WO (1) WO1998024797A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19844111A1 (en) * 1998-09-25 2000-04-20 Deutsches Krebsforsch Novel antisense nucleic acids targeted to specific sequences within the ICAM-1 gene, useful for treating inflammation and metastasis
AU6193699A (en) * 1998-09-25 2000-04-17 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1
US6114517A (en) * 1998-12-10 2000-09-05 Isis Pharmaceuticals Inc. Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
EP1146908B1 (en) * 1999-01-27 2005-08-03 Becker, David, Dr. Formulations comprising antisense nucleotides to connexins
DE10019252A1 (en) * 2000-04-18 2001-10-31 Klaus Karl Degitz Polydeoxyribonucleotides to inhibit ICAM-1 gene expression
DE10141443B4 (en) * 2001-08-23 2007-02-01 Christos C. Prof. Dr. Zouboulis Use of molecular biologically produced, non-viral agents for the treatment of acne
KR101350837B1 (en) 2003-12-03 2014-01-14 코다 테라퓨틱스, 인크. Antisense compounds targeted to connexins and methods of use thereof
KR102073629B1 (en) 2005-02-03 2020-02-05 코다 테라퓨틱스 (엔지) 리미티드 Anti-connexin compounds and uses thereof
KR20150072458A (en) 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. Improved methods and compositions for wound healing
US8063023B2 (en) 2006-12-11 2011-11-22 Coda Therapeuctics, Inc. Impaired wound healing compositions and treatments
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
EA201790434A1 (en) 2014-08-22 2017-07-31 Окленд Юнисервисиз Лимитед CHANNEL MODULATORS
WO2018199777A1 (en) 2017-04-28 2018-11-01 Auckland Uniservices Limited Methods of treatment and novel constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284931A (en) * 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US5591623A (en) * 1990-08-14 1997-01-07 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
JPH07501204A (en) * 1991-06-28 1995-02-09 マサチューセッツ インスティテュート オブ テクノロジー Topical oligonucleotide therapy
CA2082411A1 (en) * 1991-06-28 1992-12-29 Robert D. Rosenberg Localized oligonucleotide therapy
US5580969A (en) * 1992-07-24 1996-12-03 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ICAM-I RNA
EP0691853B1 (en) * 1993-04-01 2002-06-05 Isis Pharmaceuticals, Inc. ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION
WO1996015780A1 (en) * 1994-11-23 1996-05-30 Isis Pharmaceuticals, Inc. Compositions and methods for preventing and treating allograft rejection

Also Published As

Publication number Publication date
JP2001505432A (en) 2001-04-24
EP0950060A4 (en) 2000-07-05
CA2273203A1 (en) 1998-06-11
WO1998024797A1 (en) 1998-06-11
EP0950060A1 (en) 1999-10-20

Similar Documents

Publication Publication Date Title
AU2557397A (en) Removal of tissue
AU3640997A (en) Iontophoretic delivery of integrin inhibitors
AU5299696A (en) Methods of inhibiting cell-cell adhesion
AU6614696A (en) Inhibition of gene expression
AU6614596A (en) Inhibition of gene expression
AU1564897A (en) Antisense inhibition of human adhesion molecules
AU4639596A (en) Inhibition of glial cell proliferation
AU3552697A (en) Novel treatment of leptine resistance
AU4248297A (en) Inhibition of viral replication
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2585197A (en) Antisense approach to gene inhibition
AU2870597A (en) Treatment of liquid
AU1933297A (en) Manufacture of elongate members
AU5126298A (en) Inhibition of crib-biting
AU1926597A (en) Treatment of cocoa
AU1853397A (en) Treatment of pulmonary inflammation
AU3389197A (en) $(d)-erythroid kruppel-like factors and methods of use
ZA969429B (en) Amidinohydrazones of ketones
AU2222399A (en) Applicator system and method of use
AU6920898A (en) Antisense inhibition of human stat-6
AU2588000A (en) Novel adhesion molecule and methods of use
AU6034298A (en) Two human homologues of galectin-5
AU4446396A (en) Use of dihydroxyacetone
AU6578298A (en) Antisense inhibition of angiogenin expression
AU2595297A (en) Use of aminoalkylcarboxylic derivatives